Back to comparisons

Comparison

Curcumin (Turmeric) vs Memantine (Namenda)

FieldCurcumin (Turmeric)Memantine (Namenda)
Categoryneuroprotectiveneuroprotective
Dose range500–2000mg5–20mg
Half-life70h
Onset180min
EvidenceEVIDENCEBEVIDENCEA
Safety●●●●●●●●●
Legal (US)USOTCUSRx
PubMed refs140004200

The comparison in plain English

Auto-generated from data

Curcumin (Turmeric) and Memantine (Namenda) are both in the neuroprotective category respectively. Curcumin (Turmeric) Yellow pigment of turmeric root. Memantine (Namenda) Prescription NMDA receptor antagonist for moderate-to-severe Alzheimer's disease.

Bottom line

Curcumin (Turmeric) (evidence B, safety 5/5) has a stronger evidence base than Memantine (Namenda) (evidence A, safety 4/5). Curcumin (Turmeric) has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.

Choose Curcumin (Turmeric) if

Curcumin (Turmeric) is the better fit when your goal aligns with its mechanism (Inhibits NF-κB transcription factor activation, suppressing dozens of downstream pro-inflammatory cytokines (TNF-α, IL-6, IL-1β)) and the dose range (500–2000mg) suits your protocol. Half-life is —h.

Choose Memantine (Namenda) if

Memantine (Namenda) is the better fit when your goal aligns with its mechanism (Uncompetitive NMDA receptor antagonist — blocks the NMDA channel only when it's pathologically over-activated, sparing normal signaling) and the dose range (5–20mg) suits your protocol. Half-life is 70h.

Build a stack with bothOpen builder →
Check interactionsOpen checker →